{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:30:54Z","timestamp":1792438254168,"version":"4.5.0"},"reference-count":150,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSNDDT"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>Alzheimer\u2019s disease (AD) and Parkinson\u2019s disease (PD) are the two most common neurological\nillnesses that affect people in their later years. Memory loss is the hallmark of Alzheimer\u2019s disease,\nwhile dyskinesia, or loss of mobility, is associated with muscle rigidity and tremors in PD. Both\ndiseases are unrelated, however, they do have a few similarities associated with extrapyramidal abnormalities,\nparticularly stiffness, which has been linked to concomitant PD in many AD patients. Increased\nlevels of IL-1, IL-6, and TNF in the AD and PD patients can be regarded as evidence of systemic\ninflammation associated with each of these neurodegenerative disorders. One of the primary\nvariables in the progression of neurodegenerative disorders is oxidative stress. Many medicinal plants\nand their secondary metabolites have been claimed to be able to help people with neurodegenerative\ndisorders like AD and PD. Anti-inflammatory, antioxidant, antiapoptotic, monoamine oxidase inhibition,\nacetylcholinesterase, and neurotrophic pursuits are among the major mechanisms identified by\nwhich phytochemicals exert their neuroprotective effects and potential maintenance of neurological\nhealth in old age. In regard to neurodegenerative disorders, numerable plant-based drugs like alkaloids,\niridoids, terpenes, and flavones are employed for the treatment. Structure-activity relationships\n(SAR) and quantitative structure-activity relationships (QSAR) are used to investigate the link between\nbioactivity and the chemical configuration of substances. The SAR and QSAR of natural plant\ncomponents employed in AD and PD are discussed in the current review.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1871527321666220614110616","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T02:22:35Z","timestamp":1655259755000},"page":"1057-1069","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A Concise Review of Common Plant-derived Compounds as a Potential\nTherapy for Alzheimer's Disease and Parkinson's Disease: Insight into\nStructure-Activity-Relationship"],"prefix":"10.2174","volume":"22","author":[{"given":"Suchitra","family":"Nishal","sequence":"additional","affiliation":[{"name":"Swami Dayanand Post Graduate Institute of Pharmaceutical Sciences, Pt. B.D. Sharma University of Health Sciences,\nRohtak, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parmita","family":"Phaugat","sequence":"additional","affiliation":[{"name":"Drug safety Associate, Paraxel International Pvt. Ltd., Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Bazaad","sequence":"additional","affiliation":[{"name":"Drug safety Associate, Paraxel International Pvt. Ltd., Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubal","family":"Dhaka","sequence":"additional","affiliation":[{"name":"Pt. B.D. Sharma University\nof Health Sciences, Rohtak, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita","family":"Khatkar","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy and Phytochemistry, Vaish Institute of Pharmaceutical\nSciences and Research, Rohtak, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Khatkar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Maharshi Dayanand University,\nRohtak, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Khayatkashani","sequence":"additional","affiliation":[{"name":"Advanced Medical Pharma (BIOTEC), Benevento, 82100, Italy"},{"name":"Nutringredientes Research Group,\nFederal Institute of Education, Science and Technology (IFCE), Brazil"},{"name":"Instituto Federal de Educa\u00e7o Ci\u00eancia e\nTecnologia do Ceara (IFCE), Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooyan","family":"Alizadeh","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Faculty of Neurosurgery, Jundishapur University\nof Medical Sciences, Ahwaz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shima Motavalli","family":"Haghighi","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, North Khorasan University of Medical Sciences,\nBojnurd, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mehri","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, Semenan Univeristy of Medical Sciences, Semnan,\nIran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Reza Khayat","family":"Kashani","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Faculty of Neurosurgery, Shahid Beheshti University of Medical Sciences,\nTehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.neuron.2014.10.031","volume":"84","author":"Chen-Plotkin A.S.","year":"2014","unstructured":"Chen-Plotkin A.S.; Unbiased approaches to biomarker discovery in neurodegenerative diseases. Neuron 2014,84(3),594-607","journal-title":"Neuron"},{"key":"ref=2","first-page":"12","volume":"2010","author":"Wimo A.","year":"2010","unstructured":"Wimo A.; Prince M.; The global economic impact of dementia. World Alzheimer Report 2010,2010,12","journal-title":"World Alzheimer Report"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"de Lau L.M.","year":"2006","unstructured":"de Lau L.M.; Breteler M.M.; Epidemiology of Parkinson\u2019s disease. Lancet Neurol 2006,5(6),525-535","journal-title":"Lancet Neurol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000113682","volume":"5","author":"Berg D.","year":"2008","unstructured":"Berg D.; Biomarkers for the early detection of Parkinson\u2019s and Alzheimer\u2019s disease. Neurodegener Dis 2008,5(3-4),133-136","journal-title":"Neurodegener Dis"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ddtec.2016.11.003","volume":"21-22","author":"Dickmann L.J.","year":"2016","unstructured":"Dickmann L.J.; Ware J.A.; Pharmacogenomics in the age of personalized medicine. Drug Discov Today Technol 2016,21-22,11-16","journal-title":"Drug Discov Today Technol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4088\/PCC.16m02036","volume":"19","author":"Olson M.C.","year":"2017","unstructured":"Olson M.C.; Maciel A.; Gariepy J.F.; Clinical impact of pharmacogenetic-guided treatment for patients exhibiting neuropsychiatric disorders: A randomized controlled trial. Prim Care Companion CNS Disord 2017,19(2),19","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","volume":"69","author":"Group B.D.W.","year":"2001","unstructured":"Group B.D.W.; Atkinson A.J.; Colburn W.A.; Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther 2001,69(3),89-95","journal-title":"Clin Pharmacol Ther"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3389\/fnins.2018.00612","volume":"12","author":"Emamzadeh F.N.","year":"2018","unstructured":"Emamzadeh F.N.; Surguchov A.; Parkinson\u2019s disease: Biomarkers, treatment, and risk factors. Front Neurosci 2018,12,612","journal-title":"Front Neurosci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/BF03159935","volume":"14","author":"Jellinger K.A.","year":"1991","unstructured":"Jellinger K.A.; Pathology of Parkinson\u2019s disease. Changes other than the nigrostriatal pathway. Mol Chem Neuropathol 1991,14(3),153-197","journal-title":"Mol Chem Neuropathol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"e11170","DOI":"10.15252\/emmm.201911170","volume":"11","author":"Palmqvist S.","year":"2019","unstructured":"Palmqvist S.; Insel P.S.; Stomrud E.; Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer\u2019s disease. EMBO Mol Med 2019,11(12),e11170","journal-title":"EMBO Mol Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41380-020-0721-9","volume":"26","author":"Zetterberg H.","year":"2021","unstructured":"Zetterberg H.; Bendlin B.B.; Biomarkers for Alzheimer\u2019s disease-preparing for a new era of disease-modifying therapies. Mol Psychiatry 2021,26(1),296-308","journal-title":"Mol Psychiatry"},{"key":"ref=12","first-page":"377","author":"Houghton P.J.","year":"2008","unstructured":"Houghton P.J.; Howes M-J.;  In: The Chemistry Of Natural Products 2008,377","journal-title":"In: The Chemistry Of Natural Products"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000085382","volume":"14","author":"Houghton P.J.","year":"2005","unstructured":"Houghton P.J.; Howes M-J.; Natural products and derivatives affecting neurotransmission relevant to Alzheimer\u2019s and Parkinson\u2019s disease. Neurosignals 2005,14(1-2),6-22","journal-title":"Neurosignals"},{"key":"ref=14","first-page":"69","volume":"Vol. 56","author":"Khatoon S.S.","year":"2018","unstructured":"Khatoon S.S.; Rehman M.; Rahman A.;  In: Studies in natural products chemistry 2018,Vol. 56,69-127","journal-title":"In: Studies in natural products chemistry"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/biomedicines8050104","volume":"8","author":"Retinasamy T.","year":"2020","unstructured":"Retinasamy T.; Shaikh M.F.; Kumari Y.; Abidin S.A.Z.; Othman I.; Orthosiphon stamineus standardized extract reverses streptozotocin-induced Alzheimer\u2019s disease-like condition in a rat model. Biomedicines 2020,8(5),104","journal-title":"Biomedicines"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/microorganisms8020199","volume":"8","author":"Reddy V.P.","year":"2020","unstructured":"Reddy V.P.; Aryal P.; Robinson S.; Rafiu R.; Obrenovich M.; Perry G.; Polyphenols in Alzheimer\u2019s disease and in the gut-brain axis. Microorganisms 2020,8(2),199","journal-title":"Microorganisms"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"648740","DOI":"10.1155\/2014\/648740","volume":"2014","author":"Xie A.","year":"2014","unstructured":"Xie A.; Gao J.; Xu L.; Meng D.; Shared mechanisms of neurodegeneration in Alzheimer\u2019s disease and Parkinson\u2019s disease. BioMed Res Int 2014,2014,648740","journal-title":"BioMed Res Int"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"204.e13","DOI":"10.1016\/j.neurobiolaging.2010.08.010","volume":"33","author":"Wingo T.S.","year":"2012","unstructured":"Wingo T.S.; Rosen A.; Cutler D.J.; Lah J.J.; Levey A.I.; Paraoxonase-1 polymorphisms in Alzheimer\u2019s disease, Parkinson\u2019s disease, and AD-PD spectrum diseases. Neurobiol Aging 2012,33(1),204.e13-204.e15","journal-title":"Neurobiol Aging"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1159\/000329571","volume":"31","author":"Klimkowicz-Mrowiec A.","year":"2011","unstructured":"Klimkowicz-Mrowiec A.; Marona M.; Wolkow P.; Paraoxonase gene polymorphism and the risk for Alzheimer\u2019s disease in the polish population. Dement Geriatr Cogn Disord 2011,31(6),417-423","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.neulet.2004.05.108","volume":"367","author":"Clarimon J.","year":"2004","unstructured":"Clarimon J.; Eerola J.; Hellstr&#xF6;m O.; Tienari P.J.; Singleton A.; Paraoxonase 1 (PON1) gene polymorphisms and Parkinson\u2019s disease in a Finnish population. Neurosci Lett 2004,367(2),168-170","journal-title":"Neurosci Lett"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1093\/hmg\/ddn183","volume":"17","author":"Chapuis J.","year":"2008","unstructured":"Chapuis J.; Moisan F.; Mellick G.; Association study of the NEDD9 gene with the risk of developing Alzheimer\u2019s and Parkinson\u2019s disease. Hum Mol Genet 2008,17(18),2863-2867","journal-title":"Hum Mol Genet"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"809386","DOI":"10.1155\/2013\/809386","volume":"2013","author":"Dasappa J.K.","year":"2013","unstructured":"Dasappa J.K.; Nagendra H.; Preferential selectivity of inhibitors with human tau protein kinase gsk3&#x3B2; elucidates their potential roles for off-target Alzheimer\u2019s therapy. Int J Alzheimers Dis 2013,2013,809386","journal-title":"Int J Alzheimers Dis"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/2047-9158-3-6","volume":"3","author":"Zimmer E.R.","year":"2014","unstructured":"Zimmer E.R.; Leuzy A.; Bhat V.; Gauthier S.; Rosa-Neto P.; In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals. Transl Neurodegener 2014,3(1),6","journal-title":"Transl Neurodegener"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2217\/fnl.14.40","volume":"9","author":"Schilling L.P.","year":"2014","unstructured":"Schilling L.P.; Leuzy A.; Zimmer E.R.; Gauthier S.; Rosa-Neto P.; Nonamyloid PET biomarkers and Alzheimer\u2019s disease: Current and future perspectives. Future Neurol 2014,9(6),597-613","journal-title":"Future Neurol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.biocel.2010.07.016","volume":"42","author":"Lei P.","year":"2010","unstructured":"Lei P.; Ayton S.; Finkelstein D.I.; Adlard P.A.; Masters C.L.; Bush A.I.; Tau protein: Relevance to Parkinson\u2019s disease. Int J Biochem Cell Biol 2010,42(11),1775-1778","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/3311","volume":"4","author":"Conway K.A.","year":"1998","unstructured":"Conway K.A.; Harper J.D.; Lansbury P.T.; Accelerated in vitro fibril formation by a mutant &#x3B1;-synuclein linked to early-onset Parkinson disease. Nat Med 1998,4(11),1318-1320","journal-title":"Nat Med"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev.neuro.31.061307.090711","volume":"31","author":"De Vos K.J.","year":"2008","unstructured":"De Vos K.J.; Grierson A.J.; Ackerley S.; Miller C.C.; Role of axonal transport in neurodegenerative diseases. Annu Rev Neurosci 2008,31(1),151-173","journal-title":"Annu Rev Neurosci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.parkreldis.2013.09.003","volume":"20","author":"Herbert M.K.","year":"2014","unstructured":"Herbert M.K.; Eeftens J.M.; Aerts M.B.; CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls. Parkinsonism Relat Disord 2014,20(1),112-115","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.parkreldis.2003.11.005","volume":"10","author":"Kim S.","year":"2004","unstructured":"Kim S.; Seo J-H.; Suh Y-H.; &#x3B1;-synuclein, Parkinson\u2019s disease, and Alzheimer\u2019s disease. Parkinsonism Relat Disord 2004,10(Suppl. 1),S9-S13","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00401-006-0146-9","volume":"113","author":"Attems J.","year":"2007","unstructured":"Attems J.; Quass M.; Jellinger K.A.; Tau and &#x3B1;-synuclein brainstem pathology in Alzheimer disease: Relation with extrapyramidal signs. Acta Neuropathol 2007,113(1),53-62","journal-title":"Acta Neuropathol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cbi.2010.04.010","volume":"186","author":"Rivera-Manc&#xED;a S.","year":"2010","unstructured":"Rivera-Manc&#xED;a S.; P&#xE9;rez-Neri I.; R&#xED;os C.; Trist&#xE1;n-L&#xF3;pez L.; Rivera-Espinosa L.; Montes S.; The transition metals copper and iron in neurodegenerative diseases. Chem Biol Interact 2010,186(2),184-199","journal-title":"Chem Biol Interact"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1046\/j.1471-4159.2000.0740270.x","volume":"74","author":"Sayre L.M.","year":"2000","unstructured":"Sayre L.M.; Perry G.; Harris P.L.; Liu Y.; Schubert K.A.; Smith M.A.; In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer\u2019s disease: A central role for bound transition metals. J Neurochem 2000,74(1),270-279","journal-title":"J Neurochem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1212\/WNL.0b013e3181c2937c","volume":"73","author":"Benarroch E.E.","year":"2009","unstructured":"Benarroch E.E.; The locus ceruleus norepinephrine system: Functional organization and potential clinical significance. Neurology 2009,73(20),1699-1704","journal-title":"Neurology"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.mam.2005.07.010","volume":"26","author":"Arredondo M.","year":"2005","unstructured":"Arredondo M.; N&#xFA;&#xF1;ez M.T.; Iron and copper metabolism. Mol Aspects Med 2005,26(4-5),313-327","journal-title":"Mol Aspects Med"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0149-7634(00)00028-2","volume":"24","author":"Gesi M.","year":"2000","unstructured":"Gesi M.; Soldani P.; Giorgi F.S.; Santinami A.; Bonaccorsi I.; Fornai F.; The role of the locus coeruleus in the development of Parkinson\u2019s disease. Neurosci Biobehav Rev 2000,24(6),655-668","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"298","DOI":"10.2174\/1570159X11311030005","volume":"11","author":"Posadas I.","year":"2013","unstructured":"Posadas I.; L&#xF3;pez-Hern&#xE1;ndez B.; Ce&#xF1;a V.; Nicotinic receptors in neurodegeneration. Curr Neuropharmacol 2013,11(3),298-314","journal-title":"Curr Neuropharmacol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1124\/mol.110.067561","volume":"78","author":"Perez X.A.","year":"2010","unstructured":"Perez X.A.; Bordia T.; McIntosh J.M.; Quik M.; &#x3B1;6&#xDF;2* and &#x3B1;4&#xDF;2* nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: Relevance to Parkinson\u2019s disease. Mol Pharmacol 2010,78(5),971-980","journal-title":"Mol Pharmacol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2016.07.005","volume":"147","author":"Jiang T.","year":"2016","unstructured":"Jiang T.; Sun Q.; Chen S.; Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson\u2019s disease and Alzheimer\u2019s disease. Prog Neurobiol 2016,147,1-19","journal-title":"Prog Neurobiol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/07315724.2019.1683379","volume":"39","author":"Agnihotri A.","year":"2020","unstructured":"Agnihotri A.; Aruoma O.I.; Alzheimer\u2019s disease and Parkinson\u2019s disease: A nutritional toxicology perspective of the impact of oxidative stress, mitochondrial dysfunction, nutrigenomics and environmental chemicals. J Am Coll Nutr 2020,39(1),16-27","journal-title":"J Am Coll Nutr"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000085384","volume":"14","author":"Tohda C.","year":"2005","unstructured":"Tohda C.; Kuboyama T.; Komatsu K.; Search for natural products related to regeneration of the neuronal network. Neurosignals 2005,14(1-2),34-45","journal-title":"Neurosignals"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/978-981-10-8291-7_20","author":"Kaur G.","year":"2018","unstructured":"Kaur G.; Kataria H.; Mishra R.;  In: New Age Herbals 2018,437-453","journal-title":"In: New Age Herbals"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"112876","DOI":"10.1016\/j.jep.2020.112876","volume":"257","author":"Zahiruddin S.","year":"2020","unstructured":"Zahiruddin S.; Basist P.; Parveen A.; Ashwagandha in brain disorders: A review of recent developments. J Ethnopharmacol 2020,257,112876","journal-title":"J Ethnopharmacol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1248\/cpb.50.760","volume":"50","author":"Zhao J.","year":"2002","unstructured":"Zhao J.; Nakamura N.; Hattori M.; Kuboyama T.; Tohda C.; Komatsu K.; Withanolide derivatives from the roots of Withania somnifera and their neurite outgrowth activities. Chem Pharm Bull (Tokyo) 2002,50(6),760-765","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/sj.bjp.0706122","volume":"144","author":"Kuboyama T.","year":"2005","unstructured":"Kuboyama T.; Tohda C.; Komatsu K.; Neuritic regeneration and synaptic reconstruction induced by withanolide A. Br J Pharmacol 2005,144(7),961-971","journal-title":"Br J Pharmacol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"e105311","DOI":"10.1371\/journal.pone.0105311","volume":"9","author":"Baitharu I.","year":"2014","unstructured":"Baitharu I.; Jain V.; Deep S.N.; Withanolide A prevents neurodegeneration by modulating hippocampal glutathione biosynthesis during hypoxia. PLoS One 2014,9(10),e105311","journal-title":"PLoS One"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.cyto.2017.10.019","volume":"102","author":"Pandey A.","year":"2018","unstructured":"Pandey A.; Bani S.; Dutt P.; Kumar Satti N.; Avtar Suri K.; Nabi Qazi G.; Multifunctional neuroprotective effect of Withanone, a compound from Withania somnifera roots in alleviating cognitive dysfunction. Cytokine 2018,102,211-221","journal-title":"Cytokine"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1080\/07391102.2012.10507408","volume":"29","author":"Grover A.","year":"2012","unstructured":"Grover A.; Shandilya A.; Agrawal V.; Bisaria V.S.; Sundar D.; Computational evidence to inhibition of human acetyl cholinesterase by withanolide a for Alzheimer treatment. J Biomol Struct Dyn 2012,29(4),651-662","journal-title":"J Biomol Struct Dyn"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1073\/pnas.1112209109","volume":"109","author":"Sehgal N.","year":"2012","unstructured":"Sehgal N.; Gupta A.; Valli R.K.; Withania somnifera reverses Alzheimer\u2019s disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc Natl Acad Sci USA 2012,109(9),3510-3515","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2478\/s11658-007-0015-0","volume":"12","author":"Sankar S.R.","year":"2007","unstructured":"Sankar S.R.; Manivasagam T.; Krishnamurti A.; Ramanathan M.; The neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice: An analysis of behavioral and biochemical variables. Cell Mol Biol Lett 2007,12(4),473-481","journal-title":"Cell Mol Biol Lett"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neulet.2009.02.044","volume":"454","author":"Rajasankar S.","year":"2009","unstructured":"Rajasankar S.; Manivasagam T.; Surendran S.; Ashwagandha leaf extract: A potential agent in treating oxidative damage and physiological abnormalities seen in a mouse model of Parkinson\u2019s disease. Neurosci Lett 2009,454(1),11-15","journal-title":"Neurosci Lett"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jep.2009.08.003","volume":"125","year":"2009","unstructured":"RajaSankar S, Manivasagam T, Sankar V, et al. Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson\u2019s disease model mouse. J Ethnopharmacol 2009,125(3),369-373","journal-title":"J Ethnopharmacol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/978-3-319-59192-6_21","author":"Jagota A.","year":"2017","unstructured":"Jagota A.; Kowshik K.;  In: Science of Ashwagandha: Preventive and Therapeutic Potentials 2017,437-456","journal-title":"In: Science of Ashwagandha: Preventive and Therapeutic Potentials"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jep.2011.02.017","volume":"135","author":"Hu S.","year":"2011","unstructured":"Hu S.; Han R.; Mak S.; Han Y.; Protection against 1-methyl-4-phenylpyridinium ion (MPP+)-induced apoptosis by water extract of ginseng (Panax ginseng C.A. Meyer) in SH-SY5Y cells. J Ethnopharmacol 2011,135(1),34-42","journal-title":"J Ethnopharmacol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"342","DOI":"10.5142\/jgr.2012.36.4.342","volume":"36","author":"Cho I-H.","year":"2012","unstructured":"Cho I-H.; Effects of Panax ginseng in neurodegenerative diseases. J Ginseng Res 2012,36(4),342-353","journal-title":"J Ginseng Res"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jgr.2017.03.011","volume":"42","author":"Kim K.H.","year":"2018","unstructured":"Kim K.H.; Lee D.; Lee H.L.; Kim C-E.; Jung K.; Kang K.S.; Beneficial effects of Panax ginseng for the treatment and prevention of neurodegenerative diseases: Past findings and future directions. J Ginseng Res 2018,42(3),239-247","journal-title":"J Ginseng Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11481-014-9569-6","volume":"10","author":"Gonz&#xE1;lez-Burgos E.","year":"2015","unstructured":"Gonz&#xE1;lez-Burgos E.; Fernandez-Moriano C.; G&#xF3;mez-Serranillos M.P.; Potential neuroprotective activity of Ginseng in Parkinson\u2019s disease: A review. J Neuroimmune Pharmacol 2015,10(1),14-29","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"2614742","DOI":"10.1155\/2016\/2614742","volume":"2016","author":"Rokot N.T.","year":"2016","unstructured":"Rokot N.T.; Kairupan T.S.; Cheng K-C.; A role of ginseng and its constituents in the treatment of central nervous system disorders. Evid Based Complement Alternat Med 2016,2016,2614742","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.expneurol.2003.08.002","volume":"184","author":"Van Kampen J.","year":"2003","unstructured":"Van Kampen J.; Robertson H.; Hagg T.; Drobitch R.; Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson\u2019s disease. Exp Neurol 2003,184(1),521-529","journal-title":"Exp Neurol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neuint.2008.10.003","volume":"54","author":"Wang J.","year":"2009","unstructured":"Wang J.; Xu H-M.; Yang H-D.; Du X-X.; Jiang H.; Xie J-X.; Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins. Neurochem Int 2009,54(1),43-48","journal-title":"Neurochem Int"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.neuropharm.2009.09.002","volume":"58","author":"Xu H.","year":"2010","unstructured":"Xu H.; Jiang H.; Wang J.; Xie J.; Rg1 protects the MPP+-treated MES23.5 cells via attenuating DMT1 up-regulation and cellular iron uptake. Neuropharmacology 2010,58(2),488-494","journal-title":"Neuropharmacology"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1096\/fj.05-5530fje","volume":"20","author":"Chen F.","year":"2006","unstructured":"Chen F.; Eckman E.A.; Eckman C.B.; Chen F.; Eckman E.A.; Eckman C.B.; Reductions in levels of the Alzheimer\u2019s amyloid &#x3B2; peptide after oral administration of ginsenosides. FASEB J 2006,20(8),1269-1271","journal-title":"FASEB J"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.3390\/ijms20123030","volume":"20","author":"Shin S.J.","year":"2019","unstructured":"Shin S.J.; Jeon S.G.; Kim J.I.; Red ginseng attenuates A&#x3B2;-induced mitochondrial dysfunction and A&#x3B2;-mediated pathology in an animal model of Alzheimer\u2019s disease. Int J Mol Sci 2019,20(12),3030","journal-title":"Int J Mol Sci"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"4122","DOI":"10.1039\/C8FO00795K","volume":"9","author":"Lee S.","year":"2018","unstructured":"Lee S.; Youn K.; Jun M.; Major compounds of red ginseng oil attenuate A&#x3B2;25-35-induced neuronal apoptosis and inflammation by modulating MAPK\/NF-&#x3BA;B pathway. Food Funct 2018,9(8),4122-4134","journal-title":"Food Funct"},{"key":"ref=64","first-page":"29","volume":"43","author":"Song J-Q.","year":"2008","unstructured":"Song J-Q.; Chen X-C.; Zhang J.; JNK\/p38 MAPK involves in ginsenoside Rb1 attenuating beta-amyloid peptide (25-35) -induced tau protein hyperphosphorylation in embryo rat cortical neurons. Yao Xue Xue Bao 2008,43(1),29-34","journal-title":"Yao Xue Xue Bao"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jep.2016.09.007","volume":"194","author":"Zhang Y.","year":"2016","unstructured":"Zhang Y.; Pi Z.; Song F.; Liu Z.; Ginsenosides attenuate d-galactose- and AlCl3-inducedspatial memory impairment by restoring the dysfunction of the neurotransmitter systems in the rat model of Alzheimer\u2019s disease. J Ethnopharmacol 2016,194,188-195","journal-title":"J Ethnopharmacol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jgr.2014.09.002","volume":"39","author":"Tan X.","year":"2015","unstructured":"Tan X.; Gu J.; Zhao B.; Ginseng improves cognitive deficit via the RAGE\/NF-&#x3BA;B pathway in advanced glycation end product-induced rats. J Ginseng Res 2015,39(2),116-124","journal-title":"J Ginseng Res"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"98634","DOI":"10.1039\/C5RA20559J","volume":"5","author":"Ganesan P.","year":"2015","unstructured":"Ganesan P.; Ko H-M.; Kim I-S.; Choi D-K.; Recent trends of nano bioactive compounds from ginseng for its possible preventive role in chronic disease models. RSC Advances 2015,5(119),98634-98642","journal-title":"RSC Advances"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ptr.5030","volume":"28","author":"Ahmed T.","year":"2014","unstructured":"Ahmed T.; Gilani A.H.; Therapeutic potential of turmeric in Alzheimer\u2019s disease: Curcumin or curcuminoids? Phytother Res 2014,28(4),517-525","journal-title":"Phytother Res"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.2174\/09298673113209990210","volume":"20","author":"Chin D.","year":"2013","unstructured":"Chin D.; Huebbe P.; Pallauf K.; Rimbach G.; Neuroprotective properties of curcumin in Alzheimer\u2019s disease--merits and limitations. Curr Med Chem 2013,20(32),3955-3985","journal-title":"Curr Med Chem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s43440-020-00112-3","volume":"72","author":"Eghbaliferiz S.","year":"2020","unstructured":"Eghbaliferiz S.; Farhadi F.; Barreto G.E.; Majeed M.; Sahebkar A.; Effects of curcumin on neurological diseases: Focus on astrocytes. Pharmacol Rep 2020,72(4),769-782","journal-title":"Pharmacol Rep"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4103\/0972-2327.40220","volume":"11","author":"Mishra S.","year":"2008","unstructured":"Mishra S.; Palanivelu K.; The effect of curcumin (turmeric) on Alzheimer\u2019s disease: An overview. Ann Indian Acad Neurol 2008,11(1),13-19","journal-title":"Ann Indian Acad Neurol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.freeradbiomed.2007.11.011","volume":"44","author":"Jagatha B.","year":"2008","unstructured":"Jagatha B.; Mythri R.B.; Vali S.; Bharath M.M.; Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: Therapeutic implications for Parkinson\u2019s disease explained via in silico studies. Free Radic Biol Med 2008,44(5),907-917","journal-title":"Free Radic Biol Med"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10787-007-1614-0","volume":"16","author":"Rajeswari A.","year":"2008","unstructured":"Rajeswari A.; Sabesan M.; Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson\u2019s disease induced by MPTP neurodegeneration in mice. Inflammopharmacology 2008,16(2),96-99","journal-title":"Inflammopharmacology"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2174\/138161212798918995","volume":"18","author":"Mythri R.B.","year":"2012","unstructured":"Mythri R.B.; Bharath M.M.; Curcumin: A potential neuroprotective agent in Parkinson\u2019s disease. Curr Pharm Des 2012,18(1),91-99","journal-title":"Curr Pharm Des"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/iub.2209","volume":"72","author":"Forouzanfar F.","year":"2020","unstructured":"Forouzanfar F.; Read M.I.; Barreto G.E.; Sahebkar A.; Neuroprotective effects of curcumin through autophagy modulation. IUBMB Life 2020,72(4),652-664","journal-title":"IUBMB Life"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.3945\/jn.109.108001","volume":"139","author":"Allred K.F.","year":"2009","unstructured":"Allred K.F.; Yackley K.M.; Vanamala J.; Allred C.D.; Trigonelline is a novel phytoestrogen in coffee beans. J Nutr 2009,139(10),1833-1838","journal-title":"J Nutr"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"36040","DOI":"10.1074\/jbc.M206830200","volume":"277","author":"Chen J-F.","year":"2002","unstructured":"Chen J-F.; Steyn S.; Staal R.; 8-(3-Chlorostyryl)caffeine may attenuate MPTP neurotoxicity through dual actions of monoamine oxidase inhibition and A2A receptor antagonism. J Biol Chem 2002,277(39),36040-36044","journal-title":"J Biol Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","volume":"141","author":"Hampel H.","year":"2018","unstructured":"Hampel H.; Mesulam M-M.; Cuello A.C.; The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease. Brain 2018,141(7),1917-1933","journal-title":"Brain"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.bbr.2009.12.048","volume":"221","author":"Bohnen N.I.","year":"2011","unstructured":"Bohnen N.I.; Albin R.L.; The cholinergic system and Parkinson disease. Behav Brain Res 2011,221(2),564-573","journal-title":"Behav Brain Res"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/npjparkd.2016.1","volume":"2","author":"Perez-Lloret S.","year":"2016","unstructured":"Perez-Lloret S.; Barrantes F.J.; Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson\u2019s disease. NPJ Parkinsons Dis 2016,2,1","journal-title":"NPJ Parkinsons Dis"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/978-3-319-53126-7_27","author":"Perez-Lloret S.","year":"2017","unstructured":"Perez-Lloret S.; Peralta M.C.; Barrantes F.J.;  In: Psychiatry and Neuroscience Update-Vol II 2017,375-388","journal-title":"In: Psychiatry and Neuroscience Update-Vol II"},{"key":"ref=82","first-page":"CD003120","volume":"4","author":"Birks J.","year":"2002","unstructured":"Birks J.; Grimley E.; Van Dongen M.; Ginkgo biloba for cognitive impairment and dementia (Cochrane Review). Cochrane Database Syst Rev 2002,4,CD003120","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000079388","volume":"18","author":"Kurz A.","year":"2004","unstructured":"Kurz A.; Van Baelen B.; Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: A review based on meta-analyses by the cochrane collaboration. Dement Geriatr Cogn Disord 2004,18(2),217-226","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1211\/0022357001774075","volume":"52","author":"Sloley B.D.","year":"2000","unstructured":"Sloley B.D.; Urichuk L.J.; Morley P.; Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves. J Pharm Pharmacol 2000,52(4),451-459","journal-title":"J Pharm Pharmacol"},{"key":"ref=85","first-page":"105","volume":"13","author":"Rojas C.","year":"2015","unstructured":"Rojas C.; Rojas-Castaneda J.; Rojas P.; Antioxidant properties of a Ginkgo biloba leaf extract (EGb 761) in animal models of Alzheimer\u2019s and Parkinson\u2019s diseases. Curr Top Nutraceutical Res 2015,13(3),105-120","journal-title":"Curr Top Nutraceutical Res"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"430","DOI":"10.2174\/1570159X11311040006","volume":"11","author":"Tanaka K.","year":"2013","unstructured":"Tanaka K.; Galdur&#xF3;z R.F.; Gobbi L.T.; Galdur&#xF3;z J.C.; Ginkgo biloba extract in an animal model of Parkinson\u2019s disease: A systematic review. Curr Neuropharmacol 2013,11(4),430-435","journal-title":"Curr Neuropharmacol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF02859941","volume":"23","author":"Cao F.","year":"2003","unstructured":"Cao F.; Sun S.; Tong E.T.; Experimental study on inhibition of neuronal toxical effect of levodopa by Ginkgo biloba extract on Parkinson disease in rats. J Huazhong Univ Sci Technolog Med Sci 2003,23(2),151-153","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/j.1468-1331.2006.01409.x","volume":"13","author":"Mazza M.","year":"2006","unstructured":"Mazza M.; Capuano A.; Bria P.; Mazza S.; Ginkgo biloba and donepezil: A comparison in the treatment of Alzheimer\u2019s dementia in a randomized placebo-controlled double-blind study. Eur J Neurol 2006,13(9),981-985","journal-title":"Eur J Neurol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.2174\/1389201021666200320135849","volume":"21","author":"Mohammed N.A.","year":"2020","unstructured":"Mohammed N.A.; Abdou H.M.; Tass M.A.; Alfwuaires M.; Abdel-Moneim A.M.; Essawy A.E.; Oral supplements of Ginkgo biloba extract alleviate neuroinflammation, Oxidative impairments and neurotoxicity in rotenone-induced Parkinsonian rats. Curr Pharm Biotechnol 2020,21(12),1259-1268","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1515\/znc-2019-0079","volume":"75","author":"Szwajgier D.","year":"2020","unstructured":"Szwajgier D.; Borowiec K.; Zapp J.; Activity-guided isolation of cholinesterase inhibitors quercetin, rutin and kaempferol from Prunus persica fruit. Z Naturforsch C J Biosci 2020,75(3-4),87-96","journal-title":"Z Naturforsch C J Biosci"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/biom10010059","volume":"10","author":"Khan H.","year":"2019","unstructured":"Khan H.; Ullah H.; Aschner M.; Cheang W.S.; Akkol E.K.; Neuroprotective effects of quercetin in Alzheimer\u2019s disease. Biomolecules 2019,10(1),59","journal-title":"Biomolecules"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.4103\/1673-5374.211194","volume":"12","author":"Singh S.","year":"2017","unstructured":"Singh S.; Jamwal S.; Kumar P.; Neuroprotective potential of Quercetin in combination with piperine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. Neural Regen Res 2017,12(7),1137-1144","journal-title":"Neural Regen Res"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12640-019-00120-z","volume":"37","author":"Sharma S.","year":"2020","unstructured":"Sharma S.; Raj K.; Singh S.; Neuroprotective effect of quercetin in combination with piperine against rotenone- and iron supplement-induced Parkinson\u2019s disease in experimental rats. Neurotox Res 2020,37(1),198-209","journal-title":"Neurotox Res"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00217-019-03416-8","volume":"246","author":"Ahmad S.","year":"2020","unstructured":"Ahmad S.; Zeb A.; Ayaz M.; Murkovic M.; Characterization of phenolic compounds using UPLC\u2013HRMS and HPLC\u2013DAD and anti-cholinesterase and anti-oxidant activities of Trifolium repens L. leaves. Eur Food Res Technol 2020,246(3),485-496","journal-title":"Eur Food Res Technol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fphar.2020.00124","volume":"11","author":"Cassano T.","year":"2020","unstructured":"Cassano T.; Villani R.; Pace L.; From Cannabis sativa to Cannabidiol: Promising therapeutic candidate for the treatment of neurodegenerative diseases. Front Pharmacol 2020,11,124","journal-title":"Front Pharmacol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3389\/fpls.2015.01230","volume":"6","author":"Nawaz M.A.","year":"2016","unstructured":"Nawaz M.A.; Huang Y.; Bie Z.; Melatonin: Current status and future perspectives in plant science. Front Plant Sci 2016,6,1230","journal-title":"Front Plant Sci"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.neurol.2019.07.025","volume":"176","author":"Gunata M.","year":"2020","unstructured":"Gunata M.; Parlakpinar H.; Acet H.A.; Melatonin: A review of its potential functions and effects on neurological diseases. Rev Neurol (Paris) 2020,176(3),148-165","journal-title":"Rev Neurol (Paris)"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11694-019-00356-5","volume":"14","author":"Barakat A.Z.","year":"2020","unstructured":"Barakat A.Z.; Hamed A.R.; Bassuiny R.I.; Abdel-Aty A.M.; Mohamed S.A.; Date palm and saw palmetto seeds functional properties: Antioxidant, anti-inflammatory and antimicrobial activities. J Food Meas Charact 2020,14(2),1-9","journal-title":"J Food Meas Charact"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"e920250","DOI":"10.12659\/MSM.920250","volume":"26","author":"Wang S.","year":"2020","unstructured":"Wang S.; Xu J.; Zheng J.; Anti-Inflammatory and antioxidant effects of acetyl-l-carnitine on atherosclerotic rats. Med Sci Monit 2020,26,e920250-e920251","journal-title":"Med Sci Monit"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11011-019-00526-w","volume":"35","author":"Singh B.","year":"2020","unstructured":"Singh B.; Pandey S.; Rumman M.; Mahdi A.A.; Neuroprotective effects of Bacopa monnieri in Parkinson\u2019s disease model. Metab Brain Dis 2020,35(3),517-525","journal-title":"Metab Brain Dis"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"108153","DOI":"10.1016\/j.abb.2019.108153","volume":"676","author":"Dubey T.","year":"2019","unstructured":"Dubey T.; Chinnathambi S.; Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer\u2019s disease. Arch Biochem Biophys 2019,676,108153","journal-title":"Arch Biochem Biophys"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"134652","DOI":"10.1016\/j.neulet.2019.134652","volume":"716","author":"Parkhe A.","year":"2020","unstructured":"Parkhe A.; Parekh P.; Nalla L.V.; Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson\u2019s disease. Neurosci Lett 2020,716,134652","journal-title":"Neurosci Lett"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1021\/pr100049v","volume":"9","author":"Moongkarndi P.","year":"2010","unstructured":"Moongkarndi P.; Srisawat C.; Saetun P.; Protective effect of mangosteen extract against &#x3B2;-amyloid-induced cytotoxicity, oxidative stress and altered proteome in SK-N-SH cells. J Proteome Res 2010,9(5),2076-2086","journal-title":"J Proteome Res"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jnutbio.2004.05.002","volume":"15","author":"Weinreb O.","year":"2004","unstructured":"Weinreb O.; Mandel S.; Amit T.; Youdim M.B.; Neurological mechanisms of green tea polyphenols in Alzheimer\u2019s and Parkinson\u2019s diseases. J Nutr Biochem 2004,15(9),506-516","journal-title":"J Nutr Biochem"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s40263-016-0369-9","volume":"30","author":"Li Y.","year":"2016","unstructured":"Li Y.; Li L.; H&#xF6;lscher C.; Therapeutic potential of genipin in central neurodegenerative diseases. CNS Drugs 2016,30(10),889-897","journal-title":"CNS Drugs"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.freeradbiomed.2020.03.016","volume":"152","author":"Shi D.","year":"2020","unstructured":"Shi D.; Yang J.; Jiang Y.; Wen L.; Wang Z.; Yang B.; The antioxidant activity and neuroprotective mechanism of isoliquiritigenin. Free Radic Biol Med 2020,152,207-215","journal-title":"Free Radic Biol Med"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"827","DOI":"10.2174\/092986707780090954","volume":"14","author":"Ami\u0107 D.","year":"2007","unstructured":"Ami\u0107 D.; Davidovi\u0107-Ami\u0107 D.; Beslo D.; Rastija V.; Luci\u0107 B.; Trinajsti\u0107 N.; SAR and QSAR of the antioxidant activity of flavonoids. Curr Med Chem 2007,14(7),827-845","journal-title":"Curr Med Chem"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1021\/ci0500381","volume":"45","author":"Dimitrov S.","year":"2005","unstructured":"Dimitrov S.; Dimitrova G.; Pavlov T.; A stepwise approach for defining the applicability domain of SAR and QSAR models. J Chem Inf Model 2005,45(4),839-849","journal-title":"J Chem Inf Model"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.lfs.2006.11.009","volume":"80","author":"Chang H-J.","year":"2007","unstructured":"Chang H-J.; Kim H.J.; Chun H.S.; Quantitative structure-activity relationship (QSAR) for neuroprotective activity of terpenoids. Life Sci 2007,80(9),835-841","journal-title":"Life Sci"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.fct.2018.10.058","volume":"123","author":"Quintans J.S.S.","year":"2019","unstructured":"Quintans J.S.S.; Shanmugam S.; Heimfarth L.; Monoterpenes modulating cytokines - A review. Food Chem Toxicol 2019,123,233-257","journal-title":"Food Chem Toxicol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1039\/C9MD00145J","volume":"10","author":"Perusse D.","year":"2019","unstructured":"Perusse D.; Smanski M.J.; Stereoselective semi-synthesis of the neuroprotective natural product, serofendic acid. MedChemComm 2019,10(6),951-960","journal-title":"MedChemComm"},{"key":"ref=112","author":"Iuvone T.","year":"2019","unstructured":"Iuvone T.; Di Marzo V.; Guy G.; Wright S.; Stott C.; Cannabinoids for use in the treatment of neurodegenerative diseases or disorders.  US Patent US20140228438A1 2019","journal-title":"US Patent US20140228438A1"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.2174\/092986712803833335","volume":"19","author":"Gonz&#xE1;lez-Burgos E.","year":"2012","unstructured":"Gonz&#xE1;lez-Burgos E.; G&#xF3;mez-Serranillos M.P.; Terpene compounds in nature: A review of their potential antioxidant activity. Curr Med Chem 2012,19(31),5319-5341","journal-title":"Curr Med Chem"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"112163","DOI":"10.1016\/j.ejmech.2020.112163","volume":"192","author":"Li H.","year":"2020","unstructured":"Li H.; Liu Y.; Tian D.; Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer\u2019s disease. Eur J Med Chem 2020,192,112163","journal-title":"Eur J Med Chem"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s11064-014-1474-0","volume":"40","author":"Liu H.","year":"2015","unstructured":"Liu H.; Song Z.; Liao D.; Neuroprotective effects of trans-caryophyllene against kainic acid induced seizure activity and oxidative stress in mice. Neurochem Res 2015,40(1),118-123","journal-title":"Neurochem Res"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"6042","DOI":"10.1021\/jm049937r","volume":"47","author":"Siedle B.","year":"2004","unstructured":"Siedle B.; Garc&#xED;a-Pi&#xF1;eres A.J.; Murillo R.; Quantitative structure-activity relationship of sesquiterpene lactones as inhibitors of the transcription factor NF-kappaB. J Med Chem 2004,47(24),6042-6054","journal-title":"J Med Chem"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/BF02790134","volume":"47","author":"Hu J.P.","year":"1995","unstructured":"Hu J.P.; Calomme M.; Lasure A.; Structure-activity relationship of flavonoids with superoxide scavenging activity. Biol Trace Elem Res 1995,47(1-3),327-331","journal-title":"Biol Trace Elem Res"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.etap.2010.07.003","volume":"30","author":"Franco J.L.","year":"2010","unstructured":"Franco J.L.; Posser T.; Missau F.; Structure-activity relationship of flavonoids derived from medicinal plants in preventing methylmercury-induced mitochondrial dysfunction. Environ Toxicol Pharmacol 2010,30(3),272-278","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.neuint.2005.10.010","volume":"48","author":"Lu Z.","year":"2006","unstructured":"Lu Z.; Nie G.; Belton P.S.; Tang H.; Zhao B.; Structure-activity relationship analysis of antioxidant ability and neuroprotective effect of gallic acid derivatives. Neurochem Int 2006,48(4),263-274","journal-title":"Neurochem Int"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1021\/jf902951v","volume":"58","author":"Echeverry C.","year":"2010","unstructured":"Echeverry C.; Arredondo F.; Abin-Carriquiry J.A.; Pretreatment with natural flavones and neuronal cell survival after oxidative stress: A structure-activity relationship study. J Agric Food Chem 2010,58(4),2111-2115","journal-title":"J Agric Food Chem"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jep.2006.01.019","volume":"106","author":"Zhao Q.","year":"2006","unstructured":"Zhao Q.; Zhao Y.; Wang K.; Antinociceptive and free radical scavenging activities of alkaloids isolated from Lindera angustifolia Chen. J Ethnopharmacol 2006,106(3),408-413","journal-title":"J Ethnopharmacol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/1043-6618(95)80054-9","volume":"31","author":"Cassels B.K.","year":"1995","unstructured":"Cassels B.K.; Asencio M.; Conget P.; Speisky H.; Videla L.A.; Lissi E.A.; Structure-antioxidative activity relationships in benzylisoquinoline alkaloids. Pharmacol Res 1995,31(2),103-107","journal-title":"Pharmacol Res"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejmech.2014.05.002","volume":"81","author":"Huang G.","year":"2014","unstructured":"Huang G.; Kling B.; Darras F.H.; Heilmann J.; Decker M.; Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine. Eur J Med Chem 2014,81,15-21","journal-title":"Eur J Med Chem"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1021\/jm900672t","volume":"53","author":"Peng J.","year":"2010","unstructured":"Peng J.; Kudrimoti S.; Prasanna S.; Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infections. J Med Chem 2010,53(1),61-76","journal-title":"J Med Chem"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1021\/np060092r","volume":"70","author":"Hamann M.","year":"2007","unstructured":"Hamann M.; Alonso D.; Mart&#xED;n-Aparicio E.; Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure-activity relationship (SAR) studies of the manzamine alkaloids. Potential for Alzheimer\u2019s disease. J Nat Prod 2007,70(9),1397-1405","journal-title":"J Nat Prod"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ejmech.2019.03.009","volume":"169","author":"Dinda B.","year":"2019","unstructured":"Dinda B.; Dinda M.; Kulsi G.; Chakraborty A.; Dinda S.; Therapeutic potentials of plant iridoids in Alzheimer\u2019s and Parkinson\u2019s diseases: A review. Eur J Med Chem 2019,169,185-199","journal-title":"Eur J Med Chem"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2174\/138955708783955926","volume":"8","author":"Tundis R.","year":"2008","unstructured":"Tundis R.; Loizzo M.R.; Menichini F.; Statti G.A.; Menichini F.; Biological and pharmacological activities of iridoids: Recent developments. Mini Rev Med Chem 2008,8(4),399-420","journal-title":"Mini Rev Med Chem"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1055\/s-2006-959465","volume":"60","author":"Recio M.C.","year":"1994","unstructured":"Recio M.C.; Giner R.M.; M&#xE1;&#xF1;ez S.; R&#xED;os J.L.; Structural considerations on the iridoids as anti-inflammatory agents. Planta Med 1994,60(3),232-234","journal-title":"Planta Med"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"12109","DOI":"10.3390\/molecules181012109","volume":"18","author":"Carrillo-Ocampo D.","year":"2013","unstructured":"Carrillo-Ocampo D.; Bazald&#xFA;a-G&#xF3;mez S.; Bonilla-Barbosa J.R.; Aburto-Amar R.; Rodr&#xED;guez-L&#xF3;pez V.; Anti-inflammatory activity of iridoids and verbascoside isolated from Castilleja tenuiflora. Molecules 2013,18(10),12109-12118","journal-title":"Molecules"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.lwt.2006.08.019","volume":"40","author":"Es-Safi N-E.","year":"2007","unstructured":"Es-Safi N-E.; Kollmann A.; Khlifi S.; Ducrot P-H.; Antioxidative effect of compounds isolated from Globularia alypum L. structure\u2013activity relationship. Lebensm Wiss Technol 2007,40(7),1246-1252","journal-title":"Lebensm Wiss Technol"},{"key":"ref=131","first-page":"61","volume":"14","author":"Nan Z.D.","year":"2016","unstructured":"Nan Z.D.; Zhao M.B.; Zeng K-W.; Anti-inflammatory iridoids from the stems of Cistanche deserticola cultured in Tarim Desert. Chin J Nat Med 2016,14(1),61-65","journal-title":"Chin J Nat Med"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"e1800474","DOI":"10.1002\/cbdv.201800474","volume":"16","author":"Quan L.Q.","year":"2019","unstructured":"Quan L.Q.; Su L.H.; Qi S.G.; Bioactive 3,8-Epoxy iridoids from Valeriana jatamansi. Chem Biodivers 2019,16(5),e1800474","journal-title":"Chem Biodivers"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"113161","DOI":"10.1016\/j.expneurol.2019.113161","volume":"325","author":"Ji S.G.","year":"2020","unstructured":"Ji S.G.; Medvedeva Y.V.; Weiss J.H.; Zn2+ entry through the mitochondrial calcium uniporter is a critical contributor to mitochondrial dysfunction and neurodegeneration. Exp Neurol 2020,325,113161","journal-title":"Exp Neurol"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"19823","DOI":"10.3390\/molecules201119659","volume":"20","author":"Zhu T.","year":"2015","unstructured":"Zhu T.; Zhang L.; Ling S.; Qian F.; Li Y.; Xu J-W.; Anti-inflammatory activity comparison among Scropoliosides\u2014catalpol derivatives with 6-O-substituted cinnamyl moieties. Molecules 2015,20(11),19823-19836","journal-title":"Molecules"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"6149","DOI":"10.2174\/0929867326666190620103813","volume":"26","author":"Zhang L-Q.","year":"2019","unstructured":"Zhang L-Q.; Chen K-X.; Li Y-M.; Bioactivities of natural catalpol derivatives. Curr Med Chem 2019,26(33),6149-6173","journal-title":"Curr Med Chem"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"8590578","DOI":"10.1155\/2016\/8590578","volume":"2016","author":"Manoharan S.","year":"2016","unstructured":"Manoharan S.; Guillemin G.J.; Abiramasundari R.S.; Essa M.M.; Akbar M.; Akbar M.D.; The role of reactive oxygen species in the pathogenesis of Alzheimer\u2019s disease, Parkinson\u2019s disease, and Huntington\u2019s disease: A mini review. Oxid Med Cell Longev 2016,2016,8590578","journal-title":"Oxid Med Cell Longev"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"8630275","DOI":"10.1155\/2020\/8630275","volume":"2020","author":"Loffredo L.","year":"2020","unstructured":"Loffredo L.; Ettorre E.; Zicari A.M.; Oxidative stress and gut-derived lipopolysaccharides in neurodegenerative disease: Role of NOX2. Oxid Med Cell Longev 2020,2020,8630275","journal-title":"Oxid Med Cell Longev"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.freeradbiomed.2012.09.016","volume":"62","author":"Dasuri K.","year":"2013","unstructured":"Dasuri K.; Zhang L.; Keller J.N.; Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. Free Radic Biol Med 2013,62,170-185","journal-title":"Free Radic Biol Med"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrm1742","volume":"6","author":"Ross C.A.","year":"2005","unstructured":"Ross C.A.; Poirier M.A.; Opinion: What is the role of protein aggregation in neurodegeneration? Nat Rev Mol Cell Biol 2005,6(11),891-898","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13578-020-00416-0","volume":"10","author":"Xu F.","year":"2020","unstructured":"Xu F.; Na L.; Li Y.; Chen L.; Roles of the PI3K\/AKT\/mTOR signalling pathways in neurodegenerative diseases and tumours. Cell Biosci 2020,10(1),54","journal-title":"Cell Biosci"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"458","DOI":"10.2174\/1389450120666191017120505","volume":"21","author":"Hor S.L.","year":"2020","unstructured":"Hor S.L.; Teoh S.L.; Lim W.L.; Plant Polyphenols as neuroprotective agents in Parkinson\u2019s disease targeting oxidative stress. Curr Drug Targets 2020,21(5),458-476","journal-title":"Curr Drug Targets"},{"key":"ref=142","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13287-019-1294-x","volume":"10","author":"Zobel R.","year":"2019","unstructured":"Zobel R.; Levesque M.F.; Generation of dopaminergic neurons from human nervous system stem cells. Stem Cell Res Ther 2019,10,195","journal-title":"Stem Cell Res Ther"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/(SICI)1099-1573(200005)14:3<174:AID-PTR624>3.0.CO;2-O","volume":"14","author":"Bhattacharya S.K.","year":"2000","unstructured":"Bhattacharya S.K.; Bhattacharya A.; Kumar A.; Ghosal S.; Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus. Phytother Res 2000,14(3),174-179","journal-title":"Phytother Res"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fnmol.2015.00024","volume":"8","author":"Karunaweera N.","year":"2015","unstructured":"Karunaweera N.; Raju R.; Gyengesi E.; M&#xFC;nch G.; Plant polyphenols as inhibitors of NF-&#x3BA;B induced cytokine production-a potential anti-inflammatory treatment for Alzheimer\u2019s disease? Front Mol Neurosci 2015,8,24","journal-title":"Front Mol Neurosci"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.2174\/1381612826666200316125517","volume":"26","author":"Mahomoodally F.","year":"2020","unstructured":"Mahomoodally F.; Abdallah H.H.; Suroowan S.; Jugreet S.; Zhang Y.; Hu X.; In silico exploration of bioactive phytochemicals against neurodegenerative diseases via inhibition of cholinesterases. Curr Pharm Des 2020,26(33),4151-4162","journal-title":"Curr Pharm Des"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1182\/blood-2018-99-117528","volume":"132","author":"Lane S.","year":"2018","unstructured":"Lane S.; Viand F.; Bolduc K.; Ehlting J.; Walter P.B.; The potential of plant-based compounds as iron chelators. Blood 2018,132(Suppl. 1),3631-1","journal-title":"Blood"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/1541-4337.12204","volume":"15","author":"Treml J.","year":"2016","unstructured":"Treml J.; \u0160mejkal K.; Flavonoids as potent scavengers of hydroxyl radicals. Compr Rev Food Sci Food Saf 2016,15(4),720-738","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1080\/14756366.2020.1760262","volume":"35","author":"Ciccone L.","year":"2020","unstructured":"Ciccone L.; Tonali N.; Nencetti S.; Orlandini E.; Natural compounds as inhibitors of transthyretin amyloidosis and neuroprotective agents: Analysis of structural data for future drug design. J Enzyme Inhib Med Chem 2020,35(1),1145-1162","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11130-019-00791-1","volume":"75","author":"Baranowska-W&#xF3;jcik E.","year":"2020","unstructured":"Baranowska-W&#xF3;jcik E.; Szwajgier D.; Winiarska-Mieczan A.; Honey as the potential natural source of cholinesterase inhibitors in Alzheimer\u2019s disease. Plant Foods Hum Nutr 2020,75(1),30-32","journal-title":"Plant Foods Hum Nutr"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fphar.2013.00177","volume":"4","author":"Ekor M.","year":"2014","unstructured":"Ekor M.; The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 2014,4,177","journal-title":"Front Pharmacol"}],"container-title":["CNS &amp; Neurological Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871527321666220614110616","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/205943\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871527321666220614110616","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T08:19:50Z","timestamp":1691309990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/205943\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":150,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871527321666220614110616","relation":{},"ISSN":["1871-5273"],"issn-type":[{"value":"1871-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-11-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}